- Home
- EFSC vs ANIP Comparison
EFSC vs ANIP Comparison
Compare EFSC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- ANIP
- Stock Information
- Founded
- EFSC 1988
- ANIP 2001
- Country
- EFSC United States
- ANIP United States
- Employees
- EFSC N/A
- ANIP N/A
- Industry
- EFSC Major Banks
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- ANIP Health Care
- Exchange
- EFSC Nasdaq
- ANIP Nasdaq
- Market Cap
- EFSC 1.9B
- ANIP 2.0B
- IPO Year
- EFSC 1999
- ANIP N/A
- Fundamental
- Price
- EFSC $55.14
- ANIP $84.30
- Analyst Decision
- EFSC Buy
- ANIP Strong Buy
- Analyst Count
- EFSC 3
- ANIP 7
- Target Price
- EFSC $65.67
- ANIP $99.29
- AVG Volume (30 Days)
- EFSC 141.0K
- ANIP 430.4K
- Earning Date
- EFSC 10-27-2025
- ANIP 11-07-2025
- Dividend Yield
- EFSC 2.31%
- ANIP N/A
- EPS Growth
- EFSC 8.68
- ANIP N/A
- EPS
- EFSC 5.13
- ANIP 1.67
- Revenue
- EFSC $646,694,000.00
- ANIP $826,880,000.00
- Revenue This Year
- EFSC $20.14
- ANIP $40.23
- Revenue Next Year
- EFSC $5.15
- ANIP $9.65
- P/E Ratio
- EFSC $10.79
- ANIP $50.40
- Revenue Growth
- EFSC 9.31
- ANIP 48.87
- 52 Week Low
- EFSC $45.22
- ANIP $52.50
- 52 Week High
- EFSC $62.60
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- EFSC 57.07
- ANIP 43.45
- Support Level
- EFSC $51.88
- ANIP $77.99
- Resistance Level
- EFSC $55.56
- ANIP $82.12
- Average True Range (ATR)
- EFSC 1.37
- ANIP 4.26
- MACD
- EFSC 0.43
- ANIP -0.20
- Stochastic Oscillator
- EFSC 91.78
- ANIP 35.88
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.